Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells

20 Dec 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Mosquito-borne diseases and control
Share to RNA regulation and disease

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34942274
DOI: 10.1016/j.addr.2021.114087

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cellsPMID 34942274Read ↗

CRISPR/Cas mediated epigenome editing for cancer therapySemantic proximity Read ↗

CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cellsSemantic proximity Read ↗

Genome editing: CRISPR-Cas becoming more human.Semantic proximity Read ↗

RNA-programmed genome editing in human cellsSemantic proximity Read ↗

CRISPR DNA base editors with reduced RNA off-target and self-editing activitiesSemantic proximity Read ↗

CRISPR-Cas for genome editing: Classification, mechanism, designing and applicationsSemantic proximity Read ↗

An Insight into Modern Targeted Genome-Editing Technologies with a Special Focus on CRISPR/Cas9 and its ApplicationsSemantic proximity Read ↗

CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human DiseasesSemantic proximity Read ↗

CRISPR/Cas9-mediated noncoding RNA editing in human cancersSemantic proximity Read ↗

CRISPR/Cas9 Genome Editing in Oncology: Mechanisms, Therapeutic Platforms and Translational ChallengesSemantic proximity Read ↗

CRISPR/Cas based gene editing: marking a new era in medical scienceSemantic proximity Read ↗

Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.